Last reviewed · How we verify
NCT06691646
RECOGNeyes Gaze-Control Training
NA trial testing Gaze-control training game in Inattention in 35 participants. Completed in 10 January 2019.
10 January 2019
Quick facts
| Lead sponsor | University of Nottingham |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 35 |
| Start date | 4 May 2018 |
| Primary completion | 10 January 2019 |
| Estimated completion | 10 January 2019 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Gaze-control training game
Conditions studied
- Inattention — all drugs for Inattention →
- Cognitive Training — all drugs for Cognitive Training →
- Cognitive Control — all drugs for Cognitive Control →
- Oculomotor Dysfunction — all drugs for Oculomotor Dysfunction →
Sponsor
University of Nottingham
Who can join
Adults 18 to 30, any sex, with Inattention or Cognitive Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
RECOGNeyes is a computer game developed by members of the research team to improve attention in people who find it hard to "keep their eyes on the task". Players use a small eyetracker to control the game with their eyes, giving their gaze-control system (oculomotor control system) a thorough work-out. This is a "confidence-in-concept" study to see whether RECOGNeyes holds promise as an approach to improving attentional control. It takes the form of a clinical trial, in which three groups of participants will undertake different amounts of RECOGNeyes training. The goals of the study are to find out: * Whether RECOGNeyes training changes patterns of brain activity during a challenging gaze-control task. * What changes in brain activity participants show when their gaze control improves. Before and after RECOGNeyes training, participants will have two kinds of brain scan: 1. Magnetoencephalography to measure their brain waves while they do a gaze-control task that involves shifting their gaze to look either towards, or away from, an object that suddenly appears on the left or right side of a screen. It takes extra control to look away from the object as they have to actively resist the strong impulse to look towards it. 2. Functional magnetic resonance imaging of the brain while the participants are at rest in the scanner, with their eyes open. This reveals the connection patterns between different parts of the brain when the participant is not doing anything in particular. Participants will be healthy young adults, and recruitment will focus on young people who are receiving academic support for their studies, as they are more likely to have problems with "keeping their eyes on the task". They will be given sealed written instructions to play RECOGNeyes at home two, three or four times per week for two weeks, playing for 20 to 30 minutes at a time. How many times per week they are to play will be decided by random draw. From the scanning data, the researchers will: * Measure changes in brain waves and brain connectivity before and after training. * Measure improvements in the gaze-control task and how strongly the improvements relate to brain changes. * See whether the brain changes relate to how long the participants spent training. If participants who trained for longer show more improved gaze control, as well as greater brain changes, this will provide grounds for confidence in the RECOGNeyes approach to improving inattention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06691646
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Nottingham trials
Trials by the same sponsor.
- NCT07518381 — Medication Understanding in MS · not yet recruiting
- NCT07355556 — Technology Supported Improvement, Management and Prevention of Accidental Falls in Hospitals · not yet recruiting
- NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
- NCT07237529 — What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis? · NA · not yet recruiting
- NCT07237997 — Protein Supplementation During Dialysis (PROSED) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06691646 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Nottingham
- Last refreshed: 15 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06691646.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing